Gene polymorphisms of ABC transporters are associated with clinical outcomes in children with acute lymphoblastic leukemia

Archives of Medical Science

Volumn 8, Issue 4, 2012, Pages 659-671

  Zhai, Xiaowen ^a   Wang, Hongsheng ^a   Zhu, Xiaohua ^a   Miao, Hui ^a   Qian, Xiaowen ^a   Li, Jun ^a   Gao, Yijin ^a   Lu, Fengjuan ^a   Wu, Yue ^a  

^a CHILDREN S HOSPITAL OF FUDAN UNIVERSITY   (China)

Author keywords

Acute lymphoblastic leukemia; Outcome; Single nucleotide polymorphism; Survival

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CELL COUNT; CHILD; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; HUMAN; INFANT; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRESCHOOL CHILD; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL;

EID: 84866878959     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2012.30290     Document Type: Article

References (42)

1. Howlader N, Noone AM, Krapcho M et al. SEER Cancer Statistics Review, 1975-2008, National Cancer Institute. SEER Website. http://seer.cancer.gov/csr/ 1975-2008/. Accessed November 10, 2011.
2. Pui CH, Evans WE. Acute lymphoblastic leukemia. N Engl J Med 1998; 339: 605-15. (Pubitemid 28385659)
3. Apostolidou E, Swords R, Alvarado Y, Giles FJ. Treatment of acute lymphoblastic leukaemia: a new era. Drugs 2007; 67: 2153-71. (Pubitemid 47557092)
4. Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med 2006; 354: 166-78. (Pubitemid 43076714)
5. Yang JJ, Cheng C, Yang W, et al. Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lym pho - blastic leukemia. JAMA 2009; 301: 393-403.
6. De Angulo G, Yuen C, Palla SL, Anderson PM, Zweidler- McKay PA. Absolute lymphocyte count is a novel prognostic indicator in ALL and AML: implications for risk stratification and future studies. Cancer 2008; 112: 407-15.
7. Pui CH, Campana D, Pei D, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med 2009; 360: 2730-41.
8. Stock W. Adolescents and young adults with acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program 2010; 2010: 21-9.
9. Cheok MH, Pottier N, Kager L, Evans WE. Pharmacogenetics in acute lymphoblastic leukemia. Semin Hematol 2009; 46: 39-51.
10. Mattar E, Hammad L, Al-Mohammed H. Measurement and comparison of skin dose using OneDose MOSFET and mobile MOSFET for patients with acute lymphoblasic leukemia. Med Sci Monit 2011; 17: MT51-55.
11. Al-Mohammed H, Mahyoub F, Moftah B. Comparative study on skin dose measurement using MOSFET and TLD for pediatric patients with acute lymphoblastic leukemia. Med Sci Monit 2010; 16: CR325-9.
12. Ekhart C, Rodenhuis S, Smits PH, Beijnen JH, Huitema AD. An overview of the relations between polymorphisms in drug metabolising enzymes and drug transporters and survival after cancer drug treatment. Cancer Treat Rev 2009; 35: 18-31.
13. Kishi S, Cheng C, French D, et al. Ancestry and pharmacogenetics of antileukemic drug toxicity. Blood 2007; 109: 4151-7. (Pubitemid 46743376)
14. Tarr PT, Tarling EJ, Bojanic DD, Edwards PA, Baldán A. Emerging new paradigms for ABCG transporters. Biochim Biophys Acta 2009; 1791: 584-93.
15. Borst P, Elferink RO. Mammalian ABC transporters in health and disease. Annu Rev Biochem 2002; 71: 537-92. (Pubitemid 34800230)
16. Lebedeva IV, Pande P, Patton WF. Sensitive and specific fluorescent probes for functional analysis of the three major types of mammalian ABC transporters. PLoS One 2011; 6: e22429.
17. Leonard GD, Fojo T, Bates SE. The role of ABC transporters in clinical practice. Oncologist 2003; 8: 411-24. (Pubitemid 37238869)
18. Hoffmeyer S, Burk O, von Richter O, et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci U S A 2000; 97: 3473-8. (Pubitemid 30183327)
19. Huh HJ, Park CJ, Jang S, et al. Prognostic significance of multidrug resistance gene 1 (MDR1), multidrug resistancerelated protein (MRP) and lung resistance protein (LRP) mRNA expression in acute leukemia. J Korean Med Sci 2006; 21: 253-8. (Pubitemid 43763997)
20. Jamroziak K, Młynarski W, Balcerczak E, et al. Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia. Eur J Haematol 2004; 72: 314-21.
21. Jamroziak K, Balcerczak E, Cebula B, et al. Multi-drug transporter MDR1 gene polymorphism and prognosis in adult acute lymphoblastic leukemia. Pharmacol Rep 2005; 57: 882-8.
22. Rao DN, Anuradha C, Vishnupriya S, et al. Association of an MDR1 gene (C3435T) polymorphism with acute leukemia in India. Asian Pac J Cancer Prev 2010; 11: 1063-6.
23. Plasschaert SL, de Bont ES, Boezen M, et al. Expression of multidrug resistance-associated proteins predicts prognosis in childhood and adult acute lymphoblastic leukemia. Clin Cancer Res 2005; 11: 8661-8. (Pubitemid 43005914)
24. Chauhan PS, Bhushan B, Singh LC, et al. Expression of genes related to multiple drug resistance and apoptosis in acute leukemia: response to induction chemotherapy. Exp Mol Pathol 2011; 92: 44-9.
25. Jiang XJ, Wang JS, Fang Q. Gene expression of breast cancer resistance protein in adult acute lymphocytic leukemia and its clinical significance [Chinese]. J Exp Hematol 2008; 16:31-34.
26. Imanishi H, Okamura N, Yagi M, et al. Genetic polymorphisms associated with adverse events and elimination of methotrexate in childhood acute lymphoblastic leukemia and malignant lymphoma. J Hum Genet 2007; 52: 166-71. (Pubitemid 46188292)
27. Plasschaert SL, van der Kolk DM, de Bont ES, et al. The role of breast cancer resistance protein in acute lymphoblastic leukemia. Clin Cancer Res 2003; 9: 5171-7. (Pubitemid 37413566)
28. Fronkova E, Mejstrikova E, Avigad S, et al. Minimal residual disease (MRD) analysis in the non-MRD-based ALL IC-BFM 2002 protocol for childhood ALL: is it possible to avoid MRD testing? Leukemia 2008; 22: 989-97. (Pubitemid 351689881)
29. Möricke A, Zimmermann M, Reiter A, et al. Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia 2010; 24: 265-84.
30. Valera ET, Scrideli CA, Queiroz RG, Mori BM, Tone LG. Multiple drug resistance protein (MDR-1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) gene expression in childhood acute lymphoblastic leukemia. Sao Paulo Med J 2004; 122: 166-71. (Pubitemid 39545242)
31. Hunger SP, Winick NJ, Sather HN, Carroll WL. Therapy of low-risk subsets of childhood acute lymphoblastic leukemia: when do we say enough? Pediatr Blood Cancer 2005; 45: 876-80. (Pubitemid 41552154)
32. Hattori H, Suminoe A, Wada M, et al. Regulatory polymorphisms of multidrug resistance 1 (MDR1) gene are associated with the development of childhood acute lymphoblastic leukemia. Leuk Res 2007; 31: 1633-40. (Pubitemid 350051403)
33. Kimchi-Sarfaty C, Oh JM, Kim IW, et al. A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science 2007; 315: 525-8. (Pubitemid 46175758)
34. Komar AA. Silent SNPs: impact on gene function and phenotype. Pharmacogenomics 2007; 8: 1075-80. (Pubitemid 47423694)
35. Plasschaert SL, Groninger E, Boezen M, et al. Influence of functional polymorphisms of the MDR1 gene on vincristine pharmacokinetics in childhood acute lymphoblastic leukemia. Clin Pharmacol Ther 2004; 76: 220-9. (Pubitemid 39221796)
36. Urayama KY, Wiencke JK, Buffler PA, Chokkalingam AP, Metayer C, Wiemels JL. MDR1 gene variants, indoor insecticide exposure, and the risk of childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev 2007; 16: 1172-1177. (Pubitemid 46984955)
37. Cascorbi I. Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs. Pharmacol Ther 2006; 112: 457-73. (Pubitemid 44486412)
38. Yang YL, Lin DT, Chang SK, et al. Pharmacogenomic variations in treatment protocols for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2010; 54: 206-11.
39. Hitzl M, Schaeffeler E, Hocher B, et al. Variable expression of P-glycoprotein in the human placenta and its association with mutations of the multidrug resistance 1 gene (MDR1, ABCB1). Pharmacogenetics 2004; 14: 309-18. (Pubitemid 38638918)
40. Hampras SS, Sucheston L, Weiss J, et al. Genetic polymorphisms of ATP-binding cassette (ABC) proteins, overall survival and drug toxicity in patients with Acute Myeloid Leukemia. Int J Mol Epidemiol Genet 2010; 1: 201-7.
41. Ansari M, Sauty G, Labuda M, et al. Polymorphisms in multidrug resistance-associated protein gene 4 is associated with outcome in childhood acute lymphoblastic leukemia. Blood 2009; 114: 1383-6.
42. Jamroziak K, Robak T. Do polymorphisms in ABC transporter genes influence risk of childhood acute lymphoblastic leukemia? Leuk Res 2008; 32: 1173-5.